These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease. Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767 [TBL] [Abstract][Full Text] [Related]
4. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482 [TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095 [TBL] [Abstract][Full Text] [Related]
6. The inflammation-sensitive protein alpha 1-anti-chymotrypsin neutralizes fibrillar aggregation and cytotoxicity of the beta-amyloid peptide more effectively than alpha 1-antitrypsin. Giunta S; Galeazzi R; Marcellini M; Corder EH; Galeazzi L Clin Biochem; 2007 Aug; 40(12):887-92. PubMed ID: 17512513 [TBL] [Abstract][Full Text] [Related]
7. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. Ha C; Ryu J; Park CB Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909 [TBL] [Abstract][Full Text] [Related]
8. Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease. Liu ST; Howlett G; Barrow CJ Biochemistry; 1999 Jul; 38(29):9373-8. PubMed ID: 10413512 [TBL] [Abstract][Full Text] [Related]
9. Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide. Liu D; Xu Y; Feng Y; Liu H; Shen X; Chen K; Ma J; Jiang H Biochemistry; 2006 Sep; 45(36):10963-72. PubMed ID: 16953582 [TBL] [Abstract][Full Text] [Related]
10. Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors. Talmard C; Bouzan A; Faller P Biochemistry; 2007 Nov; 46(47):13658-66. PubMed ID: 17983245 [TBL] [Abstract][Full Text] [Related]
11. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment. Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906 [TBL] [Abstract][Full Text] [Related]
12. High-throughput analysis of Alzheimer's beta-amyloid aggregation using a microfluidic self-assembly of monomers. Lee JS; Ryu J; Park CB Anal Chem; 2009 Apr; 81(7):2751-9. PubMed ID: 19275225 [TBL] [Abstract][Full Text] [Related]
13. Quenched hydrogen/deuterium exchange NMR characterization of amyloid-beta peptide aggregates formed in the presence of Cu2+ or Zn2+. Olofsson A; Lindhagen-Persson M; Vestling M; Sauer-Eriksson AE; Ohman A FEBS J; 2009 Aug; 276(15):4051-60. PubMed ID: 19549187 [TBL] [Abstract][Full Text] [Related]
14. Small molecule beta-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer's disease. Hawkes CA; Deng LH; Shaw JE; Nitz M; McLaurin J Eur J Neurosci; 2010 Jan; 31(2):203-13. PubMed ID: 20074226 [TBL] [Abstract][Full Text] [Related]
15. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Ritchie CW; Bush AI; Mackinnon A; Macfarlane S; Mastwyk M; MacGregor L; Kiers L; Cherny R; Li QX; Tammer A; Carrington D; Mavros C; Volitakis I; Xilinas M; Ames D; Davis S; Beyreuther K; Tanzi RE; Masters CL Arch Neurol; 2003 Dec; 60(12):1685-91. PubMed ID: 14676042 [TBL] [Abstract][Full Text] [Related]
17. Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation. Crouch PJ; Tew DJ; Du T; Nguyen DN; Caragounis A; Filiz G; Blake RE; Trounce IA; Soon CP; Laughton K; Perez KA; Li QX; Cherny RA; Masters CL; Barnham KJ; White AR J Neurochem; 2009 Mar; 108(5):1198-207. PubMed ID: 19141082 [TBL] [Abstract][Full Text] [Related]
18. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132 [TBL] [Abstract][Full Text] [Related]
19. CLAC binds to aggregated Abeta and Abeta fragments, and attenuates fibril elongation. Kakuyama H; Söderberg L; Horigome K; Winblad B; Dahlqvist C; Näslund J; Tjernberg LO Biochemistry; 2005 Nov; 44(47):15602-9. PubMed ID: 16300410 [TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]